ACE and chronic kidney disease: Among hypertensive individuals with CKD and on antihypertensive treatment, the most frequently prescribed medications were angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ARB) [66.5% (95% CI: 61.7–71.0%)], followed by β-blockers [42.2% (95% CI: 37.0–47.5%)], diuretics [32.1% (95% CI: 27.3–37.4%)], and calcium channel blockers [28.5% (95% CI: 23.8–33.6%)].